ABSTRACT

The haemoptysis is a complication commonly reported in patients diagnosed with cystic fibrosis and affects approximately 9% of the population. It may be in limited quantity to massive events that threaten the patient’s life. Its pathogenesis is complex, but the most commonly accepted cause is persistent airway inflammation associated with neovascularization with damage to the vasculature of the bronchial arteries. The case of a 22 year old with confirmed diagnosis of cystic fibrosis in whom control of hemoptysis was achieved through embolization of bronchial arteries and placement PLUG IV Occluder device percutaneously successfully described.

KEYWORDS

Cystic fibrosis, hemoptysis, embolization, Occluder device.

REFERENCES

1. Consenso de Fibrosis Quística. Arch Argent Pediatr 1999;97(3):188-224.

2. Prados C, Máiz L, Antelo C, et al. Cystic fibrosis: consensus on the treatment of pneumothorax and massive hemoptysis and the indications for lung transplantation. Arch Bronconeumol 2000;36(7):411-416.

3. Flume PA. Pulmonary complications of cystic fibrosis. Respir Care 2009;54(5):618-627.

4. Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in cystic fibrosis. Chest 2005;128(2):729-738.

5. Charan NB, Baile EM, Paré PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997;10(5):1173-1180.

6. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001;164(10 Pt 2):S39-S45.

7. Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983;38(8):572-578.

8. Parker CM, Nolan R, Lougheed MD. Catamenial hemoptysis and pneumothorax in a patient with cystic fibrosis. Can Respir J 2007;14(5):295-297.

9. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34(2):91-100.

10. Barben JU, Ditchfield M, Carlin JB, Robertson CF, Robinson PJ, Olinsky A. Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study. J Cyst Fibros 2003;2(3):105-111.

11. Popper J. The use of premarin IV in hemoptysis. Dis Chest 1960;37:659-660.

12. Schidlow DV, Taussig LM, Knowles MR. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1993;15(3):187-198.

13. Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee; Cystic Fibrosis Foundation Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010;182(3):298-306. doi: 10.1164/rccm.201002-0157CI.

14. Coss-Bu JA, Sachdeva RC, Bricker JT, Harrison GM, Jefferson LS. Hemoptysis: a 10-year retrospective study. Pediatrics 1997;100(3):E7.

15. Sidhu M, Wieseler K, Burdick TR, Shaw DW. Bronchial artery embolization for hemoptysis. Semin Intervent Radiol 2008;25(3):310-318. doi: 10.1055/s-0028-1085931.

16. Barben J, Robertson D, Olinsky A, Ditchfield M. Bronchial artery embolization for hemoptysis in young patients with cystic fibrosis. Radiology 2002;224(1):124-130.

17. Antonelli M, Midulla F, Tancredi G, et al. Bronchial artery embolization for the management of nonmassive hemoptysis in cystic fibrosis. Chest 2002;121(3):796-801.

18. Colson DJ, Mortelliti AJ. Management of pediatric hemoptysis: review and a case of isolated unilateral pulmonary artery agenesis. Int J Pediatr Otorhinolaryngol 2005;69(9):1161-1167.

19. Hurt K, Simmonds NJ. Cystic fibrosis: management of haemoptysis. Paediatr Respir Rev 2012;13(4);200-205. doi: 10.1016/j.prrv.2012.01.003.

20. Rolla M, D’Andrilli A, Rendina EA, Diso D, Venuta F. Cystic fibrosis and the thoracic surgeon. Eur J Cardiothorac Surg 2011;39:716-725. doi: 10.1016/j.ejcts.2010.07.024

21. Ryan G, Jahnke N, Remmington T. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Cochrane Database Syst Rev 2012;12:CD008319. doi: 10.1002/14651858.CD008319.pub2.

22. Wang W, Li H, Tam MD, Zhou D, Wang DX, Spain J. The amplatzer vascular plug: a review of the device and its clinical applications. Cardiovasc Intervent Radiol 2012;35(4):725-740. doi: 10.1007/s00270-012-0387-z.

23. Graff GR. Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. Respiration 2001;68(1):91-94.

24. Sopko DR, Smith TP. Bronchial artery embolization for hemoptysis. Semin Intervent Radiol 2011;28(1):48-62. doi: 10.1055/s-0031-1273940.

25. Angle JF, Siddiqi NH, Wallace MJ, et al; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 2010;21(10):1479-1486. doi: 10.1016/j.jvir.2010.06.014.